USANA Health Sciences, Inc. (USNA)

NYSE: USNA · IEX Real-Time Price · USD
48.50
+0.23 (0.48%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Company Description

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.

The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.

It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups.

In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products.

It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau.

USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

USANA Health Sciences, Inc.
USANA Health Sciences logo
Country United States
Founded 1992
IPO Date Jul 25, 1996
Industry Packaged Foods
Sector Consumer Staples
Employees 1,800
CEO Jim Brown

Contact Details

Address:
3838 West Parkway Blvd.
Salt Lake City, Utah 84120-6336
United States
Phone (801) 954-7100
Website usana.com

Stock Details

Ticker Symbol USNA
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000896264
CUSIP Number 90328M107
ISIN Number US90328M1071
Employer ID 87-0500306
SIC Code 2833

Key Executives

Name Position
Kevin G. Guest Executive Chairman
Jim Brown Chief Executive Officer and President
G. Douglas Hekking Chief Financial Officer
Walter Noot Chief Operating Officer
David Mulham Chief Field Development Officer
Dr. Myron W. Wentz Founder and Chairman Emeritus
Dr. John Cuomo Executive Director of Product Development and Technology
Dr. Robert A. Sinnott M.N.S., Ph.D. Chief Scientific Officer
Patrique Richards Executive Director of Investor Relations and Business Development
P. Joshua Foukas Chief Legal Officer, General Counsel and Corporate Secretary

Latest SEC Filings

Date Type Title
Mar 27, 2024 ARS Filing
Mar 27, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 22, 2024 DEF 14A Other definitive proxy statements
Mar 11, 2024 144 Filing
Mar 11, 2024 144 Filing
Mar 6, 2024 144 Filing
Mar 5, 2024 144 Filing
Mar 4, 2024 144 Filing
Mar 4, 2024 144 Filing
Mar 1, 2024 144 Filing